4.7 Review

Tumor Cells Transmit Drug Resistance via Cisplatin-Induced Extracellular Vesicles

期刊

出版社

MDPI
DOI: 10.3390/ijms241512347

关键词

cisplatin; extracellular vesicles; oxidative stress; non-coding RNA; drug resistance

向作者/读者索取更多资源

Cisplatin is a first-line clinical agent used for treating solid tumors by damaging the DNA of tumor cells and inducing high levels of reactive oxygen species. Tumor cells have evolved ways to tolerate this damage. Extracellular vesicles (EVs) are an important mode of information transfer in tumor cells, and under cisplatin treatment, they can be activated and mediate different responses based on their cargoes.
Cisplatin is a first-line clinical agent used for treating solid tumors. Cisplatin damages the DNA of tumor cells and induces the production of high levels of reactive oxygen species to achieve tumor killing. Tumor cells have evolved several ways to tolerate this damage. Extracellular vesicles (EVs) are an important mode of information transfer in tumor cells. EVs can be substantially activated under cisplatin treatment and mediate different responses of tumor cells under cisplatin treatment depending on their different cargoes. However, the mechanism of action of tumor-cell-derived EVs under cisplatin treatment and their potential cargoes are still unclear. This review considers recent advances in cisplatin-induced release of EVs from tumor cells, with the expectation of providing a new understanding of the mechanisms of cisplatin treatment and drug resistance, as well as strategies for the combined use of cisplatin and other drugs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据